JOIN 200+ INVESTORS, SENIOR COMPANY EXECUTIVES AND CLINICAL THOUGHT LEADERS FOR EUROPE'S ONLY ANNUAL INVESTOR CONFERENCE FOCUSED EXCLUSIVELY ON THE CELL AND GENE THERAPY SECTOR. APPLY FOR A COMPANY PRESENTATION AND RSVP TO ATTEND TODAY!

THIS REPORT PROVIDES AN IN-DEPTH LOOK AT REGENERATIVE MEDICINE AND ADVANCED THERAPIES SECTOR TRENDS AND METRICS COMPILED FROM MORE THAN 822 LEADING THERAPEUTIC COMPANIES WORLDWIDE.

Learn more about ARM's Technology Sections - Cell Therapy, Gene & Gene-Modified Cell Therapy and Tissue Engineering & Biomaterials - created to ensure these major technology constituencies within ARM's membership are given a primary voice within the organization.